Meeting of the Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health, 77156-77157 [2024-21496]
Download as PDF
ddrumheller on DSK120RN23PROD with NOTICES1
77156
Federal Register / Vol. 89, No. 183 / Friday, September 20, 2024 / Notices
September 30, 2025, consistent with
E.O. 14109 (September 29, 2023).
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. The
ABRWH Subcommittee on Procedure
Reviews (SPR) is responsible for
overseeing, tracking, and participating
in the reviews of all procedures used in
the dose reconstruction process by the
NIOSH Division of Compensation
Analysis and Support (DCAS) and its
dose reconstruction contractor (Oak
Ridge Associated Universities—ORAU).
Matters to be Considered: The
meeting agenda will include discussions
on the following: (1) Carry-over items
from March 14, 2024 SPR meeting,
including a. DCAS–PER–040
‘‘Mallinckrodt TBD Revisions,’’ b.
DCAS–PER–068 ‘‘Electro Metallurgical
Co’’, c. DCAS–PER–070 ‘‘Nuclear Metals
Inc.’’, d. DCAS–PER–072 ‘‘Seymour
Specialty Wiring Co’’, e. ORAUT–
RPRT–0060 ‘‘Neutron Dose from Highly
Enriched Uranium’’, and f. DR template
reviews—findings versus observations;
(2) Newly issued SC&A reviews,
including a. ORAUT–OTIB–0036
‘‘Internal Dosimetry Coworker Data for
Portsmouth Gaseous Diffusion Plant’’ b.
ORAUT–OTIB–0040 ‘‘External
Coworker Dosimetry Data for the
Portsmouth Gaseous Diffusion Plant’’ c.
ORAUT–OTIB–0093 ‘‘Conversion of
Committed Effective Dose to Annual
Organ Dose’’ and d. ORAUT–RPRT–
0087 ‘‘Applications of Regression in
External Dose Reconstruction’’; (3)
Preparation for August 2024 Full
ABRWH Meeting: Review of technical
guidance documents ready for full
Board approval; (4) Newly Issued
Guidance and Supplemental Topics.
Agenda items are subject to change as
priorities dictate. For additional
information, please contact Toll Free
1(800) 232–4636.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
VerDate Sep<11>2014
16:44 Sep 19, 2024
Jkt 262001
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–21497 Filed 9–19–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Advisory Board on
Radiation and Worker Health, National
Institute for Occupational Safety and
Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the Advisory
Board on Radiation and Worker Health
(ABRWH or the Advisory Board). This
is a virtual meeting. It is open to the
public, but without a public comment
period. The public is welcome to submit
written comments in advance of the
meeting, to the contact person listed in
the addresses section below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcomed to listen to the meeting by
joining the teleconference (information
below), limited only by the number of
audio conference lines available (150).
DATES: The meeting will be held on
October 9, 2024, from 11 a.m. to 1 p.m.,
EDT.
Written comments must be received
on or before October 2, 2024.
ADDRESSES: You may submit comments
by mail to: Rashaun Roberts, Ph.D.,
National Institute for Occupational
Safety and Health, 1090 Tusculum
Avenue, Mailstop C–24, Cincinnati,
Ohio 45226.
Meeting Information: Audio
Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1–
866–659–0537; the pass code is
9933701.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
Federal Officer, National Institute for
Occupational Safety & Health, Centers
for Disease Control and Prevention,
1090 Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone
(513) 533–6800, Toll Free 1(800) 232–
4636, Email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and rechartered under Executive Order
14109 (September 29, 2023) on March
22, 2024. Unless continued by the
President the Board will terminate on
September 30, 2025, consistent with
E.O. 14109 of (September 29, 2023).
Purpose: This Advisory Board is
charged with a) providing advice to the
Secretary, HHS, on the development of
guidelines under E.O. 13179; b)
providing advice to the Secretary, HHS,
on the scientific validity and quality of
dose reconstruction efforts performed
for this program; and c) upon request by
the Secretary, HHS, advising the
Secretary on whether there is a class of
employees at any Department of Energy
facility who were exposed to radiation
but for whom it is not feasible to
estimate their radiation dose, and on
whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of
this class.
Matters to be Considered: The agenda
will include discussions on the
following: Update on Cybersecurity
Modernization Initiative; Work Group
and Subcommittee reports; Update on
E:\FR\FM\20SEN1.SGM
20SEN1
77157
Federal Register / Vol. 89, No. 183 / Friday, September 20, 2024 / Notices
the status of SEC Petitions; and plans for
the December 2024 Advisory Board
Meeting. Agenda items are subject to
change as priorities dictate. For
additional information, please contact
Toll Free 1(800) 232–4636.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–21496 Filed 9–19–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–24–24FA]
Agency Forms Undergoing Paperwork
Reduction Act Review
ddrumheller on DSK120RN23PROD with NOTICES1
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘HumanCentered Design Effort on Bringing
Guidelines to the Digital Age’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on May 7, 2024 to obtain
comments from the public and affected
agencies. CDC received two comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Form name
Clinicians .........................................................
EHR Vendors ..................................................
Guideline Developers ......................................
Informaticists ...................................................
Implementers ..................................................
Insurers ...........................................................
Patient/Patient Advocate .................................
Clinician Conversation Guide .........................
EHR Vendor Conversation Guide ..................
Guideline Developer Conversation Guide .....
Informaticist Conversation Guide ...................
Implementer Conversation Guide ..................
Insurer Conversation Guide ...........................
Patient/Patient Advocate Conversation Guide
16:44 Sep 19, 2024
Jkt 262001
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
Proposed Project
Human-Centered Design Effort on
Bringing Guidelines to the Digital Age—
Existing Collection in Use Without an
OMB Control Number—Office of Public
Health Data, Surveillance, and
Technology (OPHDST), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Given the increased demand to
improve clinical guideline development
and implementation, a new approach
that began with an initiative on
Adapting Clinical Guidelines for the
Digital Age has been expanded by
Guidelines International Network North
America to implement a future state of
guideline development and
implementation that leverages
advancements in technology. To
identify pain points in the process, there
were discussions with individuals from
multiple perspectives in guidelines
development and implementation.
CDC requests approval for an Existing
Collection in Use Without an OMB
Control Number, for Human-Centered
Design Effort on Bringing Guidelines to
the Digital Age. Data from this project
will be used to inform the structure of
a human-centered design workshop
where participants use the pain points
identified from the semi-structured
interviews as the starting point for
exploring insights about guideline
development and implementation.
The burden estimates include the
time for respondents to be interviewed.
The estimated annual burden for
respondents 33 hours. There is no cost
to respondents other than their time to
participate.
Number of
responses per
respondent
Number of
respondents
Type of respondent
VerDate Sep<11>2014
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
E:\FR\FM\20SEN1.SGM
5
2
8
4
9
1
4
20SEN1
1
1
1
1
1
1
1
Average
burden per
response
(in hours)
1
1
1
1
1
1
1
Agencies
[Federal Register Volume 89, Number 183 (Friday, September 20, 2024)]
[Notices]
[Pages 77156-77157]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21496]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Advisory Board on Radiation and Worker Health,
National Institute for Occupational Safety and Health
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Advisory Board on Radiation and Worker Health
(ABRWH or the Advisory Board). This is a virtual meeting. It is open to
the public, but without a public comment period. The public is welcome
to submit written comments in advance of the meeting, to the contact
person listed in the addresses section below. Written comments received
in advance of the meeting will be included in the official record of
the meeting. The public is also welcomed to listen to the meeting by
joining the teleconference (information below), limited only by the
number of audio conference lines available (150).
DATES: The meeting will be held on October 9, 2024, from 11 a.m. to 1
p.m., EDT.
Written comments must be received on or before October 2, 2024.
ADDRESSES: You may submit comments by mail to: Rashaun Roberts, Ph.D.,
National Institute for Occupational Safety and Health, 1090 Tusculum
Avenue, Mailstop C-24, Cincinnati, Ohio 45226.
Meeting Information: Audio Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1-866-659-0537; the pass code is
9933701.
FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated
Federal Officer, National Institute for Occupational Safety & Health,
Centers for Disease Control and Prevention, 1090 Tusculum Avenue,
Mailstop C-24, Cincinnati, Ohio 45226, Telephone (513) 533-6800, Toll
Free 1(800) 232-4636, Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines which have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule, advice on methods of dose reconstruction which have
also been promulgated by HHS as a final rule, advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program, and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC). In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC.
The charter was issued on August 3, 2001, renewed at appropriate
intervals, and rechartered under Executive Order 14109 (September 29,
2023) on March 22, 2024. Unless continued by the President the Board
will terminate on September 30, 2025, consistent with E.O. 14109 of
(September 29, 2023).
Purpose: This Advisory Board is charged with a) providing advice to
the Secretary, HHS, on the development of guidelines under E.O. 13179;
b) providing advice to the Secretary, HHS, on the scientific validity
and quality of dose reconstruction efforts performed for this program;
and c) upon request by the Secretary, HHS, advising the Secretary on
whether there is a class of employees at any Department of Energy
facility who were exposed to radiation but for whom it is not feasible
to estimate their radiation dose, and on whether there is reasonable
likelihood that such radiation doses may have endangered the health of
members of this class.
Matters to be Considered: The agenda will include discussions on
the following: Update on Cybersecurity Modernization Initiative; Work
Group and Subcommittee reports; Update on
[[Page 77157]]
the status of SEC Petitions; and plans for the December 2024 Advisory
Board Meeting. Agenda items are subject to change as priorities
dictate. For additional information, please contact Toll Free 1(800)
232-4636.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-21496 Filed 9-19-24; 8:45 am]
BILLING CODE 4163-18-P